Filing Details

Accession Number:
0001104659-18-046532
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-23 16:34:18
Reporting Period:
2018-07-20
Accepted Time:
2018-07-23 16:34:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1709401 Rubius Therapeutics Inc. RUBY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555132 A. Catherine Sohn C/O Rubius Therapeutics, Inc.
325 Vassar Street, Suite 1A
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-20 2,500 $23.00 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct